Vitamin A and its derivatives (retinoids) have profound effects on the proliferation and differentiation of many cell types and are involved in a diverse array of developmental and physiological regulatory processes, including those responsible for the development of the mature nervous system. Retinoid signals are mediated by retinoic acid (RA) receptors (RARs) and retinoid X receptors (RXRs), which show distinct spatio-temporal patterns of expression during development and in adult tissues. We have used SK-N-BE2(c) neuroblastoma cells to study the effects of reciprocal regulation of expression of various RARs. We show that in these cells RAR␥ 1 acts as a repressor of RAR␤ 2 transcription in the absence of an agonist. In the presence of RA, the expression of RAR␥ 1 is reduced and that of RAR␤ 2 is induced. Overexpression of RAR␥ 1 neutralizes the effects of RA on RAR␤ induction. Expression of an RAR␥ 1 -specific antisense construct leads to the constitutive expression of RAR␤ 2 . Although both overexpression of RAR␥ 1 and its reduction of expression can result in inhibition of cell proliferation, they induce different morphological changes. Reduction of RAR␥ 1 (and induction of RAR␤) leads to increased apoptosis, whereas RAR␥ 1 overexpression leads to differentiation in the absence of apoptosis. Thus, RAR␥ 1 appears to control a differentiation-apoptosis switch in SK-N-BE2(c) neuroblastoma cells.
Retinoids, the natural and synthetic derivatives of vitamin A, are known to regulate a broad range of biological processes, including vertebrate development, growth, and differentiation (24, 40, 56) . The common denominator for these various effects is the ability of retinoids to trigger regulatory switches, modifying the repertoire of genes expressed by a given cell (24) . The effects of retinoids are mediated by two families of ligand-responsive regulators, i.e., retinoic acid (RA) receptors (RARs) and retinoid X receptors (RXRs), which are members of the nuclear receptor superfamily (8, 22, 23, 30, 31, (42) (43) (44) (45) 52) . RARs bind and are activated by all-trans-RA and 9-cis-RA, whereas RXRs bind and are activated only by 9-cis-RA (26, 38) . Both types of receptors are coded for by three genes (␣, ␤, and ␥) from which multiple isoforms can be generated by the use of alternative promoters or differential splicing (29, 37, 71) . Differential tissue distribution of the various isoforms suggests that they may possess functional specificity, and given the pleiotropic effects of RA, it has been suggested that a fine tuning of retinoid receptor expression levels might be an essential requirement for correct development (9, 14, 58) . RARs and RXRs modulate the expression of their target genes by binding to RA response elements (RAREs) (46, 67) . One such RARE is located in the RAR␤ 2 promoter region, and it has been shown that this response element mediates RAR␤ 2 induction in response to RA in several cell lines and tissues (13, 27, 62) . This autoregulation of the RAR␤ gene is thought to play an important role in amplifying the RA response, thereby enhancing the final biological response. This is supported by recent studies which have shown that altered receptor expression can be associated with tumor development: for example, RAR␤ is not expressed in certain malignant tumors, including lung carcinomas and breast carcinomas (21, 63, 72, 73) . A subclone of the RA-responsive murine P19 embryonal carcinoma cells carrying an RAR␣ mutation was found to be RA resistant (55) . Similarly, an RA-resistant subclone of HL60 (human myeloid leukemia) cells was found to have a dominant negative RAR␣ (11) , while F9 murine teratocarcinoma cells with disrupted RAR␥ genes exhibit an altered differentiation response (7) . Other studies, however, suggest that individual retinoid receptors may not perform unique functions, since mice carrying null mutations for RAR␣ 1 or RAR␥ 2 showed no obvious abnormalities (31, 39) .
Retinoids have also been implicated in many aspects of neuronal differentiation. Depending on the time of RA administration, teratogenic doses of RA cause defects in neural tube closure (3) , and one of the most sensitive teratogenic targets is the neural crest (50) .
Neuroblastoma (NB) is the most common extracranial malignant solid tumor of childhood; it arises from neural crest cell derivatives, and retinoids can induce its differentiation in vitro (5, 12, 66) , generating a neuronal phenotype and causing a marked reduction in cell proliferation (1, 2, 60, 61) . In contrast to the differentiation-promoting activity of RA, the synthetic analog N-(4-hydroxyphenyl)retinamide dramatically suppresses NB cell growth by inducing programmed cell death (54) . NB cells therefore appear to represent a suitable model to investigate the mechanisms of neuronal cell death apoptosis and its relation to differentiation. RAR␣ and RAR␥ have been found to be constitutively expressed in NB cells, while RAR␤ upregulation depends on the presence of RA (19, 69) . RAR␤, which could be involved in the ontogenesis of the nervous system (47, 58) , is one of the genes known to be induced by RA in cells that have the neuronal phenotype (10) . The effects of RA on the differentiation of NB cells do not depend entirely on the induction of RAR␤, since in the NB cell line LAN-5, RAR␤ 2 is constitutively expressed but differentiation takes place only in the presence of high concentration of RA, while the LAN-1 cell line can differentiate in the presence of RA even in the absence of RAR␤ 2 (19, 69) .
The present study was undertaken to identify the roles that the different RAR subtypes play in the RA response and differentiation pathway. The SK-N-BE2(c) cell line, selected for these studies, expresses RAR and RXR subtypes, and RAR␤ 2 induction has been reported as an early marker of the RA response (19) . We show here that RAR␥ 1 controls the expression of the RAR␤ 2 gene and, most interestingly, that the levels of RAR␥ 1 , independently of RA addition, are critical for the expression of different cell phenotypes with modified growth rates. In addition, we observed a correlation between the levels of RAR␥ 1 and the induction of differentiation or apoptosis.
MATERIALS AND METHODS
Cell cultures. The human NB SK-N-BE2(c) cells used in this study were kindly provided by G. Tonini (G. Gaslini Children's Hospital, Genova, Italy) and grown in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 1% glutamine, and 1% nonessential amino acids.
All-trans-RA (Sigma) was dissolved in ethanol at the concentration of 5 mM and kept at Ϫ80°C. Stock solutions of retinoid antagonists CD2331 and CD2366 (2 mM) were made in a dimethyl sulfoxide-ethanol (1:1) mixture and were maintained at Ϫ20°C. Further dilutions were made in culture medium.
RT-PCR. Reverse transcription-PCR (RT-PCR) was performed under previously described conditions (18, 20) with, as primers, specific oligonucleotides that allow the unequivocal distinction between receptor subtypes and isoforms (20) . For each analysis the quantity and quality of RNA were normalized by the coanalysis of ␤-actin messenger (20) .
Plasmids. Plasmids pECE-RAR (␣, ␤, and ␥) and pECE-RXR␣ have been previously described (35, 53) . For stable RAR␥ 1 transfection, the BamHI insert from pSG5 hRAR␥ 1 , kindly provided by P. Chambon, was inserted into the BamHI site of the eukaryotic expression vector pH␤ Apr-1-neo (25) , and the correct sense orientation was determined by restriction analysis. To obtain the RAR␥ 1 -specific antisense expression vector, the BalI/BstXI fragment from pSG5 hRAR␥ 1 was made blunt and cloned into the EcoRV site of pBluescript SK. The EcoRI/HindIII insert was subsequently cloned into the EcoRI/HindIII sites of pH␤ Apr-1-neo and analyzed for the correct orientation.
Stable transfections. The recombinant constructs were stably transfected into SK-N-BE2(c) cells by the DOTAB method (Boehringer Mannheim) and screened with 400 g of G418 (Gibco BRL) per ml. Clones were obtained through serial dilutions. To allow for cell growth, total transfectants and clones were cultured in the presence of the specific antagonist and routinely frozen within 1 week of culture. Experiments utilizing transfected cells were conducted on freshly thawed cells cultured in regular medium. Antagonists were added when needed. The expression of exogenous RAR␥ 1 sense and antisense cDNAs was evaluated by RT-PCR or Northern blotting.
Transient transfection and CAT assay. Transient transfections were carried out by using a modified calcium phosphate precipitation procedure, as described previously (53) , with green monkey kidney cells (CV-1) grown in Dulbecco's modified Eagle's medium supplemented with 10% FCS. To measure the transcriptional activation, TREpal-tk linked with the chloramphenicol acetyltransferase (CAT) gene was used as a reporter gene. Briefly, 100 ng of reporter gene, 200 ng of ␤-galactosidase expression vector (pCH110; Pharmacia), and 50 ng of receptor expression vector were mixed with carrier DNA (pBluescript; Stratagene) to give a total of 1,000 ng of total DNA per well. After the cells were grown in the presence of the various retinoids for 24 h, CAT and ␤-galactosidase activities were assayed as previously described (53) . CAT activity was normalized for transfection efficiency by the corresponding ␤-galactosidase activity.
Western blotting and immunostaining analyses. Ten micrograms of DNAbinding proteins (4) was resolved by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis on 10% gels and electroblotted onto a polyvinylidene difluoride (PVDF) membrane. The membrane was reacted with specific anti-RAR and anti-RXR antibodies (Santa Cruz), and protein bands were visualized after addition of enhanced chemiluminescence detection reagent (Amersham) by following the manufacturer's protocol.
Cytoskeletal proteins were detected by using the 2H3 monoclonal antibody (Developmental Studies Hybridoma Bank) against 165-kDa neurofilaments. Monoclonal antibodies to CD4 receptor were used as a negative control. A positive control for differentiation was obtained by treating SK-N-BE2(c) cells with 10 M RA for 4 days. Slides were fixed in 4% paraformaldehyde, followed by 10 min at Ϫ20°C in ethanol-acetic acid (95:5), and incubated with the diluted antibody. After a second incubation with biotin-conjugated rabbit anti-mouse immunoglobulins (Amersham), the complex was reacted with peroxidase-conjugated streptavidin (Amersham) and visualized with 3-amino-9-ethylcarbazole.
Evaluation of apoptosis and DNA fragmentation detection. Cells were plated at 15,000/ml on chamber slides and grown as described above. After fixation with cold 2% formaldehyde in phosphate-buffered saline (PBS), the cells were washed with cold PBS and the nuclei were stained with a solution containing 50 g of propidium iodide per ml, 0.1% Triton X-100, 0.1% Na citrate, and 20 g of RNase A per ml in PBS for 15 to 20 min at room temperature. Apoptotic nuclei were identified by fluorescence microscopy. DNA fragmentation was measured on floating and adherent cells; 2 ϫ 10 6 cells for each experiment were lysed and treated as described by Bissonette et al. (6) .
Flow cytometric analysis. Adherent and floating cells were fixed in 70% ethanol, washed twice in PBS, and resuspended in DNA staining solution containing 30 g of propidium iodide per ml and 0.5 mg of RNase A per ml. DNA flow cytometric measurements were performed on an EPICS Elite instrument (Coulter Corporation, Miami, Fla.), and the Muticycle program (Phoenix Flow Systems, San Diego, Calif.) was used for the analysis of the cell cycle distribution as well as for the evaluation of apoptotic cells.
Cell proliferation assay. To study anchorage-dependent cell growth, mocktransfected SK-N-BE2(c) cells and sense or antisense transgene cells were seeded at 1,000 to 3,000 cells per well (depending on the time in culture) in 96-well plates and grown in regular medium or treated with various concentrations of retinoid antagonists. Media were changed every 48 h. The number of viable cells was measured by the capacity of cells to reduce nitroblue tetrazolium with a colorimetric cell proliferation kit (MTT assay; Promega) (51).
RESULTS

Induction of RAR␤ 2 correlates with a transient decrease of RAR␥ 1 in SK-N-BE2(c) cells.
We used an RT-PCR protocol that allows for semiquantitative analysis of RAR and RXR subtype and isoform expression (20) . We observed that SK-N-BE2(c) cells constitutively express RAR␣ 1 , RAR␥ 1 , RAR␥ 2 , RXR␣, and RXR␤ (Fig. 1A) . Consistent with previous observations (19) , exposure to physiological concentrations of RA (10 nM) led to the induction of RAR␤ 2 mRNA, whereas the mRNA levels for the other retinoid receptors were not affected (Fig. 1B) . Figure 2A shows that SK-N-BE2(c) cells constitutively express high levels of RAR␥ 1 mRNA; RAR␤ 2 expression is weak, but upon stimulation by RA, it increases strongly in a time-dependent manner. RAR␤ 2 induction correlated with a decrease in RAR␥ 1 mRNA, suggesting that expression of both RAR␥ 1 and RAR␤ 2 is controlled by RA in NB cells. RAR␣ 1 , RAR␥ 2 , and RXR␣ and -␤ expression did not change after exposure to RA (data not shown). To assess whether the RAR␥ 1 mRNA decrease was associated with a decrease of its protein, nuclear extracts were analyzed. Western blot analysis of nuclear extracts from control cells and cells exposed to 10 nM RA revealed a reduction in RAR␥ 1 protein at 2 h after RA addition (Fig. 2B ). When the same blot was reprobed with anti-RAR␣ and anti-RXR antibodies, no differences between RA- treated and control cells could be detected. Antibodies to RAR␤ did not recognize specific bands in these analyses.
RAR␥ 1 limits RA-dependent transactivation of the RAR␤ 2 gene. It has been observed that RAR␥ 1 does not act as an RA-dependent activator of the RAR␤ 2 promoter but acts as a transcriptional repressor (27, 28) . We investigated whether overexpression of RAR␥ 1 could reduce the RA-induced transcription of RAR␤ 2 in SK-N-BE2(c) cells. The coding region of human RAR␥ 1 was placed under the control of the human ␤-actin promoter, and stable transfectants were selected. In Fig. 3A , expression levels of endogenous and transfected RAR␥ 1 in three different clones are compared to those for control cells (transfected with the empty vector). To verify the data, RNA levels were also analyzed by Northern blotting, and two bands corresponding to 3.3 and 1.5 kb, as expected, were seen (Fig. 3B) . Clones overexpressing RAR␥ 1 were investigated in detail to assess their ability to respond to RA as measured by the activation of the RAR␤ 2 gene. Control clones that contained empty vector and three RAR␥ 1 -overexpressing clones were grown in the presence of increasing concentrations 6 cells per 25-cm 2 tissue culture flask, and after an overnight incubation at 37°C, RA was added (time zero) to a final concentration of 10 nM. At various times after RA addition, total RNA was isolated and 1 g was analyzed by RT-PCR for RAR or RXR expression as described in the text. Values for RAR and RXR mRNAs were normalized to that for ␤-actin mRNA used as internal standard for each RNA sample. The degree of amplification was quantitated by scanning densitometry and plotted as a ratio of RAR to ␤-actin or RXR to ␤-actin. Only data relative to RAR␤ 2 and RAR␥ 1 are reported, since no modulations were observed for the remaining RARs and RXRs. Five independent experiments with very similar results were conducted. OD, optical density. (B) Ten micrograms of DNA-binding proteins obtained from control cells and cells exposed to 10 nM RA was electrophoresed on SDS-polyacrylamide gels, transferred to PVDF membranes, and probed with antibodies against RAR␣, RAR␥, or RXR. Lanes 1, control cells; lanes 2, cells exposed to RA for 90 min; lanes 3 to lane 9, treated cells collected every 30 min. Prestained molecular size standards were used to identify bands of the correct molecular weight. of RA for 24 h to achieve maximal induction of RAR␤ 2 . An RT-PCR analysis of RNA samples is shown in Fig. 3C . A clear correlation between expression levels of RAR␥ 1 and inducibility of RAR␤ 2 was observed: 10 nM RA was sufficient to induce RAR␤ 2 mRNA in control cells (empty vector clones), while in the RAR␥ 1 -transfected clones, increasing the levels of exogenous RAR␥ 1 antagonized the effects of RA. Interestingly, relatively small increases in RAR␥ 1 levels clearly affected RAR␤ 2 expression (the relative amounts of endogenous versus transfected RAR␥ 1 were estimated by scanning densitometry of Fig.  3A ). For instance clone 1, where RAR␥ 1 mRNA is augmented 0.5-fold, is resistant to 10 nM RA but still responds to higher concentrations of RA. When the RAR␥ 1 levels are doubled (clone 2), 100 nM RA no longer induces the RAR␤ 2 gene, while the most striking effect is observed in clone 3 (with the highest levels of transfected RAR␥ 1 ), where the cells have become resistant to even 1 M RA. Thus, we observed an RAR␥ 1 -dependent inhibition of the RAR␤ 2 response to RA in the NB cells, consistent with the previously observed repression of the RAR␤ 2 promoter by RAR␥ 1 (27, 28) 
To further analyze the involvement of RAR␥ 1 in the regulation of the RA transduction signals in NB cells, we downregulated its expression by using RAR␥ 1 -specific antisense cDNA. RAR␥ 1 differs from RAR␥ 2 in its NH 2 -terminal region corresponding to the BalI/BstXI fragment of human RAR␥ 1 cDNA (29, 36) . As can be seen from Fig. 4 , stable transfected cells show detectable levels of RAR␥ 1 antisense expression as determined by Northern blotting. When RAR mRNA expression in cells grown either in FCS-containing medium or in the absence or presence of 10 nM RA was assessed, comparable levels of constitutive RAR␤ 2 expression were observed in both samples (Fig. 4) . Interestingly, comparing clones expressing RAR␥ 1 sense or antisense transgenes, we noticed clear morphological differences. Two clones, expressing the highest levels of transgenes, were analyzed in more detail. Compared to empty-vector-transfected cells (Fig. 5a ), sense transgene-transfected cells (Fig. 5c) showed a more differentiated phenotype, with neurite-like processes resembling those of wild-type cells differentiating in the presence of 10 M RA (Fig. 5b) . Conversely, antisense transgene-transfected cells were relatively round with branched neurites, and a large portion of them became shrunken and eventually detached (Fig. 5d) . In both cases the morphological changes were observed in the absence of exogenously added RA.
These clones were further analyzed to study the effects of RAR␥ 1 sense or antisense transgenes. The clones showed an appreciable level of transgene expression (data not shown), and Western blot immunostaining revealed an increase of RAR␥ 1 protein in sense transgene-transfected cells and a decrease of the molecule in antisense transgene-transfected cells (Fig. 6A) . Comparing their growth rate to that of cells transfected with the empty vector, we observed that both the overexpression of RAR␥ 1 and its reduction (coupled to RAR␤ 2 induction) lead to a strong growth inhibition (Fig. 6B) . Cell growth in other clones transfected with either sense or antisense constructs was analyzed, and the levels of transgene expression were proportional to the extent of growth inhibition (data not shown). Thus, very low as well as very high levels of RAR␥ 1 appear to inhibit proliferation of SK-N-BE2(c) cells. RAR␥ 1 levels allow for a switch between neuronal maturation and cell death. Morphological changes and cytoskeletal protein expression are typical hallmarks of neuronal maturation in NB cell lines, and microscopic inspection of our cell lines showed a similarity between sense transgene-transfected cells (Fig. 5c ) and cells exposed for 4 days to 10 M RA (Fig.  5b) . Neurofilaments, specific markers of neurons, were assessed by immunostaining in control, RA-treated, and transgene-containing cells by utilizing the 2H3 monoclonal antibody, which is specific for the 165-kDa neurofilaments. RA treatment (Fig. 7C) caused a shift in the localization of the staining from a diffuse somatic pattern (characteristic of control cells [ Fig. 7B] ) to an intense perinuclear and neuritic pattern (Fig. 7C) , which became more apparent in RAR␥ 1 -overexpressing cells (Fig. 7D) .
In contrast, the morphology of antisense transgene-transfected cells (Fig. 5d) was consistent with that of cells dying by programmed cell death (17, 70) . When nuclei of adherent cells were stained with propidium iodide and examined by fluorescence microscopy (Fig. 8A, panel c) , we found that 15% of the cells were smaller and contained condensed and fragmented nuclei with brightly stained chromatin, morphological changes typical of apoptosis. Conversely, sense transgene-transfected cells (Fig. 8A, panel b) showed no alteration in chromatin structure and were similar to control cells in this assay (panel a). During apoptosis, loss of membrane integrity is preceded by chromatin condensation and internucleosomal cleavage of genomic DNA, which produces a characteristic ladder pattern when analyzed by agarose gel electrophoresis (70) . When such analyses were performed, we observed strong DNA fragmentation which was absent in control and sense transgene-transfected cells (Fig. 8B) . This further confirms that the growth inhibitions observed with sense and antisense transgene-transfected cells result from the induction of different biological programs.
RAR␤ 2 -and RAR␥ 1 -specific antagonists selectively counteract RA effects. Receptor-selective antagonists can be used as alternative tools to evaluate the roles of individual receptors. We therefore used RAR␤-and RAR␥-selective antagonists to further evaluate the roles of RAR␤ and RAR␥ in the regulation and induction of specific programs in the NB cells. From several compounds reported to possess antagonist activity (34), we selected CD2331 and CD2366. When RAR␣, -␤, and -␥ and RXR␣ expression vectors were cotransfected with a TREpal-tk-CAT reporter gene into CV-1 cells, both CD2331 and CD2366 were unable to activate the reporter gene (Fig. 9) . Conversely, in the presence of RA the antagonists caused a dose-dependent reduction of transactivation by RAR␤ 2 and RAR␥ 1 , respectively (Fig. 9) . At the highest nontoxic antago- nist concentration (1 M), CD2331 could completely suppress the transactivation induced by RAR␤ 2 in the presence of 10 nM RA, while CD2366 inhibited more than 80% of RAR␥ 1 -mediated transactivation under the same conditions. The two compounds were ineffective when tested in the presence of RAR␣ (Fig. 9 ) or 9-cis-RA-activated RXR␣ (data not shown). These results show that CD2331 antagonizes selectively the transactivation of RAR␤ 2 by RA, while CD2366 antagonizes selectively the transactivation of RAR␥ 1 . In both cases a 100-fold excess of the antagonist over RA was required for complete inhibition. If RAR␥ 1 is directly involved in the transduction of the RA signal in SK-N-BE2(c) cells, CD2366 should be able to antagonize this action, and we could expect that the addition of the antagonist to cells exposed to RA prevents RAR␤ gene induction. In Table 1 the inhibitory activity of CD2366 on RAR␤ induction by RA is shown. When used at 1 M, CD2366 completely inhibits induction of RAR␤ mRNA by 10 nM RA and partially inhibits induction by 100 nM RA. CD2331 was also tested under the same conditions, and no inhibitory effects on RAR␤ mRNA synthesis were observed (data not shown).
CD2331 and CD2366 partially counteract inhibition of cell proliferation in transfected SK-N-BE2(c) cells. We also assessed the ability of the antagonists to counteract retinoidinduced growth inhibition. To avoid clonal effects due to position-insertion, total transfectant populations were studied. The transfected cultures showed an appreciable level of transgene expression (data not shown), and Western blot immunostaining revealed an increase of RAR␥ 1 protein in sense transgene-transfected cells (Fig. 10A ) and a decrease of the molecule in antisense transgene-transfected cells (Fig. 10B ). Cells were seeded in the presence of increasing concentration of antagonists to evaluate their effects on cell proliferation. On the basis of the antagonist properties, cells overexpressing RAR␥ 1 were cultured in the presence of CD2366, while CD2331 was utilized to antagonize RAR␤ 2 being constitutively expressed in RAR␥ 1 antisense transgene-transfected cells. Cell proliferation was evaluated by the MTT assay. Growth curves obtained in the presence of 1 M antagonists are shown in Fig.  10 . Lower antagonist concentrations were ineffective in this assay. CD2366 allowed sense transgene-transfected cells (Fig.  10A ) to grow faster, with a maximal effect observed at day 8, at which point the growth rate was comparable to that of control cells that lacked the sense transgene. The growth rate of the antisense transgene-transfected cells (Fig. 10B) was partially restored by the addition of CD2331, suggesting that RAR␤ 2 does contribute to cell growth arrest. Indeed, flow cytometric analysis of antisense transgene-transfected cells revealed an apoptotic peak (about 68%) and a decrease in the fraction of S-and G 2 -plus M-phase cells (Fig. 11B) , while antagonist treatment (4 days at 1 M) decreased the apoptotic peak to 16% and normalized the cell cycle distribution (Fig. 11C) .
DISCUSSION
In this study we demonstrate a ligand-sensitive transcriptional cross talk between RAR␥ 1 and RAR␤ 2 in SK-N-BE2(c) cells. Our findings support the existence of a regulatory interplay between members of the retinoid receptor superfamily, consistent with data reported by other groups.
Several studies have suggested that RAR␥ 1 inhibits the activation of the ␤RARE by other RARs (28) ; this function is not due to a general lack of transcriptional enhancer activity of the receptor, since other response elements are efficiently activated (28, 33) . A similar conclusion was reached also by Taneja et al. (65), who studied the contribution of RARs and RXRs to the activation of RA target genes by using RAR subtype (␣, ␤, or ␥)-specific synthetic retinoids. They observed that even though all three RARs can functionally substitute for each other as activators of RA target genes, one RAR subtype can cell specifically override the activity of the other RAR subtypes, and RAR␥ can suppress RAR␤ 2 expression in wild-type F9 cells by a mechanism that involves the inhibition of RAR␣-dependent induction of RAR␤ 2 (65) . This inhibitory effect of RAR␥ 1 is likely to be of biological significance for the containment of RA-mediated responses via activation of the ␤RARE. It is tempting to speculate that the reciprocal tissue expression patterns of RAR␥ and RAR␤ might in part be due to such a mechanism. Indeed, unlike RAR␣, RAR␤ and RAR␥ show restricted and mutually exclusive spatio-temporal patterns of expression during embryonic development (15, 58) . Ruberte et al. (58) have shown the presence of RAR␤ transcripts in the closed neural tube, while RAR␥ transcripts become undetectable at the time of neural tube closure and are absent from the central and peripheral nervous systems throughout development (59) . A similar nonoverlapping distribution of RAR␤ and RAR␥ transcripts was also seen in the developing limb and in the inner ear region; for the latter region, RAR␥ transcripts are present only in the otic capsule, whereas RAR␤ transcripts are found in the mesenchyme surrounding the inner ear epithelium (59) . The direct involvement of RAR␥ in the transduction of the RA signal was also shown in vivo, as RAR␥ null mutant mice display some of the abnormalities present in animals fed a vitamin A-deficient diet (39) and do not display some of the teratogenic effects caused by maternal RA administration (39) .
We have demonstrated that in our system RAR␥ 1 can repress RAR␤ 2 induction and RAR␤ 2 levels determine the inhibition of cell proliferation and induction of apoptosis. A correlation between high levels of RAR␤ expression and apoptosis has also been observed in vivo in cells in the interdigital regions of the developing limb, in the fusion region of the neural tube, and in the palate (32, 48) . Repression of RAR␤ gene transcription by RAR␥ 1 most likely involves competitive binding between RAR␥ and RAR␣-RXR heterodimers to the ␤RARE. Both RAR␥ and RAR␣ have been shown to bind to this RARE, but while RAR␣ is an effective activator of this response element, RAR␥ is not (28) . This might explain why even relatively small increases in RAR␥ can have substantial effects on RAR␤ induction even in the presence of RA and why high RA concentrations can still induce RAR␤ 2 through RAR␣ upregulation (69) . Not unexpectedly, RAR␥ 1 may also be able to substitute for some (but not all) RAR␤ 2 functions (Fig. 5) , since overexpression of RAR␥ 1 leads to a phenotype similar to that observed in normal cells in the presence of 10 M RA. It is well known that RAR␥ 1 has high constitutive activity (28) that may allow it to substitute for the RAR␥ 1 and RAR␤ 2 activity observed in wild-type cells at 10 M RA. The apparent discrepancy between results obtained when express- ing RAR␥ antisense or inhibiting RAR␥ by a specific antagonist are most easily explained by the very different modes of action of these two agents. RAR␥ 1 antagonists allow continuous blocking of the ␤RARE by RAR␥-RXR heterodimers. In fact, it is likely that the antagonist represses the activation of RARE-containing genes by constitutively inhibiting RAR␥ activity (28) . Thus, RAR␥ antagonists can still allow repression of RAR␤ expression and thereby avoid apoptosis but allow cell proliferation. In contrast, RAR␥ antisense expression eliminates or reduces RAR␥ expression, thereby allowing binding of RAR␣-RXR or RAR␤-RXR heterodimers to the ␤RARE and induction of RAR␤ (by low concentrations of RA present under the growth conditions) and thus progression towards apoptosis. The orphan receptor nur77 might also function as an activator of the ␤RARE under those conditions and add to RAR␤ induction (68) . The observation that RAR␤ antagonists strongly inhibit this pathway indicates that induction of other RAR␤-responsive genes is part of this signaling cascade.
Although it has been shown that certain RAR␥-selective compounds with retinoid-like activities can induce apoptosis (16, 41) , it is generally believed that RAR␥ can induce cell differentiation. In fact, only RAR␥ can mediate the RA-induced differentiation of wild-type F9 cells (65) , and the overexpression of RAR␥ directly induces terminal differentiation of human embryonal carcinoma NT2/D1 cells into a neuronal phenotype (49) . Conversely, the overexpression of RAR␣ and -␤ and RXR␣ does not produce maturation or growth-inhibitory effects (49) . In agreement with these findings, we detect a differentiated phenotype in SK-N-BE2(c) cells overexpressing RAR␥ 1 ; the direct involvement of RAR␥ in cell growth arrest and differentiation is further demonstrated by the effects of an RAR␥-selective antagonist capable of restoring the normal cell growth rate.
A functional redundancy between RARs in vivo and in vitro has been described (31, 57, 64) , and the upregulation of the remaining RARs in F9 cells, in which a single RAR has been disrupted, may be sufficient for the maintenance of several functions (64) . This is not the case for our antisense transgenetransfected cells, where the loss of RAR␥ 1 and its repressor role cannot be replaced by RAR␤ 2 , suggesting that RAR␥ 1 has a particular role in the regulation of genes that control cell growth and differentiation. Thus, our data suggest that both RAR␥ 1 and RAR␤ 2 can control cell growth but that they play distinct roles in determining cell differentiation or apoptosis.
Our study also shows that changes in RAR isoform expression levels can lead to dramatically different effects on the fate of a cell population. Thus, a high level of complexity appears to govern nuclear receptor function in vivo.
